Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. (December 2016)

Record Type:
Journal Article
Title:
Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. (December 2016)
Main Title:
Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
Authors:
Fischer, M.
Wulff, B.
Baruchel, S.
Berlanga, P.
Trahair, T.
Mechinaud, F.
Schulte, J.
Modak, S.
Merks, J.H.
Zwaan, C.M.
Marshall, L.V.
Casanova, M.
Branle, F.
Malet, I.
Emeremni, A.C.
Geoerger, B.
Abstract:
Is Part Of:
European journal of cancer. Volume 69(2016)supplement 1
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Issue Display:
Volume 69, Issue 2016 (2016)
Year:
2016
Volume:
69
Issue:
2016
Issue Sort Value:
2016-0069-2016-0000
Page Start:
S49
Page End:
S50
Publication Date:
2016-12
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(16)32732-0 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2630.xml